Rights and permissions
About this article
Cite this article
Lower costs with fluticasone propionate vs leukotriene antagonists. Pharmacoecon. Outcomes News 382, 9 (2002). https://doi.org/10.1007/BF03279670
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279670